Search by Drug Name or NDC

    NDC 81749-0004-01 Tarpeyo 4 mg/1 Details

    Tarpeyo 4 mg/1

    Tarpeyo is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Calliditas Therapeutics AB. The primary component is BUDESONIDE.

    Product Information

    NDC 81749-0004
    Product ID 81749-004_fd1ce4f1-f790-4c27-ac31-b2108e8e7a80
    Associated GPIs 22100012006520
    GCN Sequence Number 082942
    GCN Sequence Number Description budesonide CAPSULE DR 4 MG ORAL
    HIC3 P5A
    HIC3 Description GLUCOCORTICOIDS
    GCN 51745
    HICL Sequence Number 006545
    HICL Sequence Number Description BUDESONIDE
    Brand/Generic Brand
    Proprietary Name Tarpeyo
    Proprietary Name Suffix n/a
    Non-Proprietary Name budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name BUDESONIDE
    Labeler Name Calliditas Therapeutics AB
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215935
    Listing Certified Through 2025-12-31

    Package

    NDC 81749-0004-01 (81749000401)

    NDC Package Code 81749-004-01
    Billing NDC 81749000401
    Package 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01)
    Marketing Start Date 2021-12-15
    NDC Exclude Flag N
    Pricing Information N/A